MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,127,000 | -75.0% | 374,300 | -69.4% | 0.15% | -70.9% |
| Q1 2022 | $100,512,000 | -34.2% | 1,222,477 | +17.4% | 0.52% | -34.2% |
| Q4 2021 | $152,765,000 | -24.4% | 1,041,417 | -8.8% | 0.80% | -27.6% |
| Q3 2021 | $202,065,000 | +18.6% | 1,142,193 | +8.3% | 1.10% | +14.1% |
| Q2 2021 | $170,337,000 | +81.1% | 1,054,522 | +92.1% | 0.96% | +63.1% |
| Q1 2021 | $94,039,000 | +27.2% | 548,971 | +63.1% | 0.59% | +26.3% |
| Q4 2020 | $73,944,000 | +16.7% | 336,660 | -11.8% | 0.47% | -3.1% |
| Q3 2020 | $63,379,000 | +69.3% | 381,682 | +16.4% | 0.48% | +47.0% |
| Q2 2020 | $37,428,000 | +20.3% | 327,830 | -19.0% | 0.33% | -1.8% |
| Q1 2020 | $31,108,000 | +13.9% | 404,679 | +90.9% | 0.33% | +36.3% |
| Q4 2019 | $27,309,000 | +228.4% | 211,931 | +98.6% | 0.24% | +184.9% |
| Q3 2019 | $8,315,000 | – | 106,724 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |